Lamisil is a targeted and clinically proven antifungal containing 1% terbinafine hydrochloride, trusted and recommended by HCPs worldwide
All Lamisil antifungal products are formulated with fungicidal terbinafine, an allylamine, which targets an earlier step in the ergosterol biosynthesis pathway than azoles1. Its mechanism enables effective treatment in as little as 1 week for skin infections, compared with the longer courses often required for azole antifungals. This in turn, may lead to improved adherence.


Condition
Coming soon

Patient Advice
Coming soon

Resources
Coming soon
References
- Ryder NS. Br J Dermatol. 1992;126(29):2-7.
- Schafer-Korting M, et al. Skin Pharmacol Physiol. 2008;21:203–210
- J Am Acad Dermatol. 1992; 26(6): 956-60; Data on File.

